secwatch.observer — SEC 8-K summary
======================================

Issuer:     GreenLight Biosciences Holdings, PBC (—)
CIK:        0001822691
Form:       8-K/A
Filed at:   2023-07-28T23:59:59+00:00
Accession:  0001193125-23-196931
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GreenLight Biosciences completes going-private merger; stock delisted at $0.30/share
--------------------------------------------------------------------------------

- Merger with SW ParentCo closed July 24, 2023; stockholders received $0.30 per share cash.
- Aggregate consideration ~$9.3M for shares not rolled over; 60.4% of outstanding shares tendered.
- Concurrent $52.075M financing led by Fall Line Capital; $15M advanced pre-closing.
- CEO Andrey Zarur continues leading combined company; new sole director Clay Mitchell.
- Warrant holders must exercise by August 23, 2023 to receive reduced exercise price and $0.0220 Black-Scholes value.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822691/000119312523196931/0001193125-23-196931-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822691/000119312523196931/d495956d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-196931

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer